NEOGENOMICS INC — Director's Dealing 2022

Nov 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-11-03

Reporting Person: Perez David Brian (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-03	Common Stock	A	10300	—	Acquired	10300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-03	Stock Option (Right to Buy)	$7.34	A	9730	Acquired	2029-06-10	Common Stock (9730.0)	Direct

Footnotes

F1: On November 3, 2022, Mr. Perez was granted 10,300 restricted stock awards. These awards vest on June 10, 2023.